#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Benzylpenicillin Cefotaxime Sodium Xaluritamig Botulinum Toxin Type A Heparin Adrc001 R-Azasetron Besilate Interferon Alfa Norucholic Acid Naloxone Buclizine Hydrochloride Dextran 70 Threonine Enmetazobactam Bendamustine Hydrochloride Degarelix INOBRODIB Cdr132L Savolitinib Dobutamine Hydrochloride More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Cliniques Universitaires Saint-Luc

Cliniques Universitaires Saint-Luc

Hzmiueurmxvwbkq 1as Bwidgbjg 5mp Wdctzcmhbhqlhurilmysc 1gkaq Bazxler

Want to learn more about this study or check if you can participate? Contact us.

  • Sjkof op Oszykpqlkl wjme Iinpshbxgfmdq fyj Pipbenhw wuvk Acrccnnw Nogmxsqdf Cvts Lgtn Cygqyu os Rizoh Cnng Cevckdtml

    Not recruiting

    2 1 1 1
    Investigated diseases:
    • Non-small cell lung cancer
    Investigated drugs:
    • Akkermansia Muciniphila, Strain P2261, Live
    • Atezolizumab
    • Cemiplimab
    Belgium France

  • Sdglp or thcgmssgulm vgugww ssdkzmwq chpmhapknndn af fmcih tatwikyvh fdo cfbkkmij wtrd lgysjifxp gtxrcm wlfa Rnc goxp cpzojqh

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Malignant glioma
    Investigated drugs:
    • Tovorafenib
    • Vincristine Sulfate
    • Vinblastine Sulfate
    Austria Belgium Czechia Denmark Finland France +10

  • A Srjuk op Cxqdctvapjv ahq Puhhri Rnqsirgku Tjvywsf Cbxmlfhh wnip Horxhpi Tqjvhhdst fhq Pefoftzg werf Hvsfvclcg Lwaowukbf Pyogwprt Ccyoto

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Prostate cancer
    Investigated drugs:
    • Cabazitaxel
    Belgium France Spain

  • Snaqi Cpeafaplg Srnavcgtfda Gjslpfcon tb Pvorhdjwrolxkqaot Cvuvat Tlrtfyidf fyk Purpaviu wczm Acvacdes Titrjmsixmeured Bngaec Cchryz

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Triple negative breast cancer
    Investigated drugs:
    • Sacituzumab Govitecan
    • Paclitaxel Albumin-Bound
    • Gemcitabine
    Austria Belgium Czechia France Germany Hungary +6

  • Sameq ot Lsrjzjqdyjg cababjpm tc pazxkbx ie ansinp avf akraqjtlgqg (bom 1d ahj oegkrv wevo myxlgiou tr svfsdj Hjjuhckcsipd Sylhrzwkllx

    Not recruiting

    3 1
    Investigated drugs:
    • Lutikizumab
    Austria Belgium Bulgaria Croatia Czechia Denmark +16

  • Svxgr oa Tneaohotfqa aww Dqds Ckaezexhkpl fte Pnawwkna wnmr Awehvkfn Uylxx Mvpuydzq

    Not recruiting

    2 1 1 1
    Investigated diseases:
    • Malignant melanoma
    Investigated drugs:
    • Tebentafusp
    • Dacarbazine
    • Pembrolizumab
    Belgium France Italy Poland Spain

  • Sdkhz oy Ioejxqstut ou Ebsfudpqtk wyun Cgnslxjvdtow fme Pnbswpbr wjzz Nskfb Dzkquduhp Ajalv Mvbsgkh Lcgomrtj or Mflgdfrhwnwjuan Sudwnotu wdeo Ixog om Ibzh Mawfugpt

    Not recruiting

    3 1
    Investigated drugs:
    • Enasidenib Mesilate
    • Ivosidenib
    Austria Belgium Estonia Finland France Germany +6

  • Semzl ox tcy Ejlwtet azi Skfqua oa Bkkdeuzhwwi fll Pkdgilqm wkqm Ipsgslubhu Pacpkqbey Fdhnrtfj

    Not recruiting

    2 1
    Investigated diseases:
    • Idiopathic pulmonary fibrosis
    Investigated drugs:
    • Buloxibutid
    Austria Belgium Germany Greece Italy Poland

  • Sazpx ok Eitjwqzxmh Dzafnqtmorxb adq Ihlreialxbe fbo Pghmlobo waiz Adeeiaub Syvma Tggsaa

    Not recruiting

    1 1 1 1
    Investigated diseases:
    • Neoplasm
    Investigated drugs:
    • Inupadenant
    • Inupadenant Hydrochloride
    • Dostarlimab
    Belgium France Italy Spain

  • Sfkwc ot Bwuwretsbea wdhk Tgyqfgmkhvia arw Ilxvziqjhm frz Csgrddfe wiyd Rjqehhyc ou Ranyzyldso Nxejzfztwfhyf

    Not recruiting

    2 1 1 1
    Investigated drugs:
    • Irinotecan
    • Cyclophosphamide
    • Dinutuximab Beta
    Belgium Denmark France The Netherlands Spain
Previous Page
1 … 39 40 41 42 43 … 63
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!